• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双氢青蒿素抑制K562细胞中血管内皮生长因子的表达

[Dihydroartemisinin inhibits the expression of vascular endothelial growth factor in K562 cells].

作者信息

Li Jun, Zhou Hui-jun

机构信息

Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310031, China.

出版信息

Yao Xue Xue Bao. 2005 Nov;40(11):1041-5.

PMID:16499092
Abstract

AIM

To study the effect of dihydroartemisinin (DHA) on vascular endothelial growth factor (VEGF) expression in K562 cells and assess the effect of DHA on leukemic angiogenesis induced by K562 cells.

METHODS

Firstly, analyzed the anti-proliferation effect of DHA on K562 cells and assessed the inhibitory effect on expression of VEGF in K562 cells. Further, the conditioned medium (CM) of K562 cells pretreated with DHA was assessed for its stimulating effect on proliferation of endothelial cells and angiogenesis on chicken chorioallantoic membrane (CAM) model.

RESULTS

DHA effectively inhibited the proliferation of K562 cells in vitro, and the IC50 was 13.08 micromol x L(-1). The VEGF level of K562 cells was significantly lowered after treated with DHA for 48 h, even at a lower concentration (2 micromol x L(-1), P < 0.05). The stimulating effect on proliferation of endothelial cells and angiogenesis on CAM model were weakened in response to the CM from K562 cells pretreated with DHA in a dose-dependent manner.

CONCLUSION

DHA could effectively downregulate the VEGF expression in K562 cells, and inhibit the leukemic angiogenesis induced by K562 cells.

摘要

目的

研究双氢青蒿素(DHA)对K562细胞血管内皮生长因子(VEGF)表达的影响,并评估DHA对K562细胞诱导的白血病血管生成的作用。

方法

首先,分析DHA对K562细胞的抗增殖作用,并评估其对K562细胞中VEGF表达的抑制作用。进一步地,评估用DHA预处理的K562细胞的条件培养基(CM)对内皮细胞增殖的刺激作用以及在鸡胚绒毛尿囊膜(CAM)模型上的血管生成作用。

结果

DHA在体外有效抑制K562细胞的增殖,IC50为13.08微摩尔×L(-1)。用DHA处理48小时后,即使在较低浓度(2微摩尔×L(-1))下,K562细胞的VEGF水平也显著降低(P < 0.05)。用DHA预处理的K562细胞的CM对内皮细胞增殖和CAM模型上血管生成 的刺激作用以剂量依赖方式减弱。

结论

DHA可有效下调K562细胞中VEGF的表达,并抑制K562细胞诱导的白血病血管生成。

相似文献

1
[Dihydroartemisinin inhibits the expression of vascular endothelial growth factor in K562 cells].双氢青蒿素抑制K562细胞中血管内皮生长因子的表达
Yao Xue Xue Bao. 2005 Nov;40(11):1041-5.
2
Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells.青蒿琥酯抑制慢性髓性白血病K562细胞的血管生成并下调血管内皮生长因子的表达。
Vascul Pharmacol. 2007 Aug-Sep;47(2-3):131-8. doi: 10.1016/j.vph.2007.05.002. Epub 2007 May 24.
3
Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells.双氢青蒿素下调慢性髓性白血病K562细胞中血管内皮生长因子的表达并诱导其凋亡。
Cancer Chemother Pharmacol. 2006 Jan;57(2):213-20. doi: 10.1007/s00280-005-0002-y. Epub 2005 Aug 2.
4
[Dihydroartemisinin down-regulates the expression of transferrin receptor in myeloid leukemia cells].双氢青蒿素下调髓系白血病细胞中转铁蛋白受体的表达
Yao Xue Xue Bao. 2008 Jun;43(6):576-83.
5
Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion.双氢青蒿素在缺氧条件下通过下调血管内皮生长因子表达及抑制血管内皮生长因子分泌,抑制多发性骨髓瘤RPMI8226细胞诱导的血管生成。
Anticancer Drugs. 2006 Aug;17(7):839-48. doi: 10.1097/01.cad.0000224443.85834.32.
6
[Suppressive effect of artesunate on K562 cell growth and its influence on VEGF expression].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):777-80.
7
Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence.通过反义血管内皮生长因子(VEGF)序列的表达抑制K562白血病血管生成和生长。
Cancer Gene Ther. 2003 Dec;10(12):879-86. doi: 10.1038/sj.cgt.7700645.
8
Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells.安罗替尼与双氢青蒿素联合治疗对改善胃癌细胞恶性生物学行为的作用及其机制。
Curr Pharm Biotechnol. 2021;22(4):523-533. doi: 10.2174/1389201021666200623132803.
9
Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.青蒿琥酯对血管生成以及血管内皮生长因子和VEGF受体KDR/flk-1表达的抑制作用
Pharmacology. 2004 May;71(1):1-9. doi: 10.1159/000076256.
10
[Dihydroartemisinin inhibits proliferation and induces apoptosis of rat glioma C6 cells].双氢青蒿素抑制大鼠胶质瘤C6细胞增殖并诱导其凋亡
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 May;36(3):267-72. doi: 10.3785/j.issn.1008-9292.2007.03.010.

引用本文的文献

1
Dihydroartemisinin-regulated mRNAs and lncRNAs in chronic myeloid leukemia.双氢青蒿素对慢性粒细胞白血病中mRNA和lncRNA的调控
Oncotarget. 2017 Dec 15;9(2):2543-2552. doi: 10.18632/oncotarget.23274. eCollection 2018 Jan 5.
2
The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells.谷氨酰胺酶-1抑制剂968增强双氢青蒿素对肝癌细胞的抗肿瘤疗效。
PLoS One. 2016 Nov 11;11(11):e0166423. doi: 10.1371/journal.pone.0166423. eCollection 2016.
3
Development of artemisinin compounds for cancer treatment.
青蒿素类化合物在癌症治疗方面的发展。
Invest New Drugs. 2013 Feb;31(1):230-46. doi: 10.1007/s10637-012-9873-z. Epub 2012 Aug 31.
4
Artemisinins: their growing importance in medicine.青蒿素:它们在医学领域日益重要。
Trends Pharmacol Sci. 2008 Oct;29(10):520-7. doi: 10.1016/j.tips.2008.07.004. Epub 2008 Aug 25.